Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC).

about

Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC).

Item

http://www.wikidata.org/entity/Q52642515

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Systematic review of outcome m ...... tment of anal cancer (CORMAC).

@en

Systematic review of outcome m ...... r the treatment of anal cancer

@nl

type

Item

label

Systematic review of outcome m ...... tment of anal cancer (CORMAC).

@en

Systematic review of outcome m ...... r the treatment of anal cancer

@nl

prefLabel

Systematic review of outcome m ...... tment of anal cancer (CORMAC).

@en

Systematic review of outcome m ...... r the treatment of anal cancer

@nl

P1476

Systematic review of outcome m ...... tment of anal cancer (CORMAC).

@en

P2093

A G Renehan

http://www.w3.org/2001/XMLSchema#string

N Ryan

http://www.w3.org/2001/XMLSchema#string

P R Williamson

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial.

Developing core outcomes sets: methods for identifying and including patient-reported outcomes (PROs).

Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.

Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer.

Efficacy and toxicity of chemoradiation in patients with anal cancer--a retrospective analysis.

One compared with two cycles of mitomycin C in chemoradiotherapy for anal cancer: analysis of outcomes and toxicity.

The COMET Handbook: version 1.0.

Quality of life and tumor control after short split-course chemoradiation for anal canal carcinoma.

P304

371-382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CODI.14103

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Caroline Sanders

Sabine N van der Veer

Rebecca Fish

P577

2018-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29566456

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

5969105

http://www.w3.org/2001/XMLSchema#string